“Molecular Docking and ADMET Profiling of Novel Human Dipeptidyl Peptidase-IV Inhibitors of Natural Origin from Dalbergia sissoo: In Silico Prediction in Antidiabetic Potential” (2024) International Journal of Pharmaceutical Sciences and Drug Research, 16(5), pp. 841–854. doi:10.25004/IJPSDR.2024.160512.